Agilent launches Gen5 AI cell identification module for BioTek automated imagers

By Public Technologies
  • Agilent launched a Gen5 AI Cell Identification Module to add AI-based cell identification and segmentation to BioTek Gen5 imaging workflows.
  • Software targets compatible BioTek Cytation and Lionheart automated imagers, aiming to cut manual steps in cell counting and confluence analysis.
  • AI segmentation removes conventional threshold setting or parameter tuning, a source of user-driven variability in high-throughput image analysis.
  • Module supports label-free or fluorescence assays, including live-cell or kinetic formats used in life science and drug research.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agilent Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609290800BIZWIRE_USPR_____20260929_BW497412) on September 29, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.